Is Star Imaging and Path Lab Ltd (544482) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Star Imaging and Path Lab Ltd is a below average quality company .

Is Star Imaging and Path Lab Ltd (544482) undervalued or overvalued?

The key valuation ratios of Star Imaging and Path Lab Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Star Imaging and Path Lab Ltd (544482) share price return in the past 10 years?

Data is not available for this company

Is Star Imaging and Path Lab Ltd (544482) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Star Imaging and Path Lab Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Star Imaging and Path Lab Ltd (544482)?

Company share prices are keep on changing according to the market conditions. The current trading price of Star Imaging and Path Lab Ltd (544482) on 17-Apr-2026 16:59:59 at 16:59 is 83.07.

What is the P/E ratio of Star Imaging and Path Lab?

The latest standalone P/E ratio of Star Imaging and Path Lab as of 17-Apr-2026 is 9.09.

What is the P/B ratio of Star Imaging and Path Lab Ltd (544482)?

The latest standalone P/B ratio of Star Imaging and Path Lab Ltd (544482) as of 17-Apr-2026 is 1.25.

What is the 52-week high and low of Star Imaging and Path Lab Ltd (544482)?

The 52-week high of Star Imaging and Path Lab Ltd (544482) is Rs. 152.00 and the 52-week low is Rs. 46.00.

Star Imaging and Path Lab Ltd (544482) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Star Imaging and Path Lab Ltd (544482)
Brand: Star Imaging and Path Lab

Star Imaging and Path Lab Ltd (544482) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Star Imaging and Path Lab Ltd (544482)

BSE: 544482 NSE:

Key Metrics

Market Cap

₹145 Cr.

P/E Ratio

9.09

Price to Book (P/B)

1.25

Price to Sales (P/S)

1.74

EV/EBITDA

5.97

Return on Capital Employed (ROCE)

33.71%

Current Price

₹83.1

Return on Equity (ROE)

40.63%

Return on Assets (ROA)

17.76%

Operating Profit Margin

34.3%

Net Profit Margin

19.12%

Gross Profit Margin

31.6%

Book Value per Share

₹66.3

Sales Growth (YoY)

6.04%

Sales Growth (3 Years)

6.48%

Operating Profit Growth (1 Year)

26.78%

Operating Profit Growth (3 Years)

24.85%

Net Profit Growth (1 Year)

28.93%

52-Week Low / High

₹46 / 152

Net Profit Growth (3 Years)

36.17%

Dividend Yield

0.00%

Promoter Holding

71.92%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Star Imaging and Path Lab Ltd?

Star Imaging and Path Lab Ltd revenue growth is 6% for FY-2025 , which is above its 5 year CAGR of 0% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Star Imaging and Path Lab Ltd?

Promoters hold 71.92% of the Star Imaging and Path Lab Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Star Imaging and Path Lab Ltd vs industry peers?

Star Imaging and Path Lab Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 1.49% , indicating slower growth and losing its market share.

Q.1 Which industry/sub-sector does Star Imaging and Path Lab Ltd belong to?

Star Imaging and Path Lab Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.

Q.1 Stock return of Star Imaging and Path Lab Ltd over the last decade?

Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

DeciZen - make an informed investing decision on Star Imaging & Path

Based on:

Data

Overall Rating ⓘ
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation

3. Price Trend

Star Imaging and Path Lab stock performance

Key Ratios

Is Star Imaging and Path Lab Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	23.7%	6.1%	34.4%	33.7%	-
Value Creation Index ⓘ	0.7	-0.6	1.5	1.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	68.9	58.4	78.5	83.2	83
Sales YoY Gr.	-	-15.3%	34.5%	6%	-
Adj EPS ⓘ	4.7	0.4	8.6	11.8	9.1
YoY Gr.	-	-91%	1952.4%	36.8%	-
BVPS (₹) ⓘ	13.6	14	23.2	34.9	66.3
Adj Net Profit ⓘ	6.3	0.6	11.6	15.9	16
Cash Flow from Ops. ⓘ	14.4	6.5	18.3	-6	-
Debt/CF from Ops. ⓘ	2.1	4.1	1.7	-5.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	6.5%	6%
Adj EPS ⓘ	NA	NA	36.3%	36.8%
BVPSⓘ	NA	NA	36.9%	50.5%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	34.3	3.1	46.4	40.6	18.1
Op. Profit Mgn % ⓘ	21.3	10.3	28.7	34.3	NAN
Net Profit Mgn % ⓘ	9.1	1	14.8	19.1	19.1
Debt to Equity ⓘ	1.6	1.4	1	0.7	-
Working Cap Days ⓘ	0	232	195	254	0
Cash Conv. Cycle ⓘ	0	45	39	107	0

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	9.1	9.1
TTM Sales (₹ Cr.)	83.2	83.5
BVPS (₹) ⓘ	66.3	66.4
Reserves (₹ Cr.) ⓘ	98	98
P/BV ⓘ	1.25	1.25
PE ⓘ	9.09	9.09

From the Market
52 Week Low / High (₹)	46.00 / 152.00
All Time Low / High (₹)	46.00 / 152.00
Market Cap (₹ Cr.)	145
Equity (₹ Cr.)	17.4
Face Value (₹)	10
Industry PE ⓘ	86.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Star Imaging & Path - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'22	Mar'23	Mar'24	Mar'25
Sales	69	58	79	83
Operating Expenses ⓘ +	54	52	56	55
Manufacturing Costs	26	26	31	28
Material Costs	11	8	8	7
Employee Cost	9	8	7	7
Other Costs ⓘ	9	10	9	13
Operating Profit ⓘ	15	6	23	29
Operating Profit Margin (%)	21.3%	10.3%	28.7%	34.3%
Other Income ⓘ +	0	0	1	0
Exceptional Items ⓘ	0	0	0	0
Interest ⓘ	2	2	2	3
Depreciation ⓘ	4	3	5	5
Profit Before Tax ⓘ	9	1	16	21
Tax ⓘ	3	0	4	5
Profit After Tax	6	1	12	16
PAT Margin (%)	9.1%	1.0%	15.7%	19.1%
Adjusted EPS (₹)	4.7	0.4	9.1	11.8
Dividend Payout Ratio (%)	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	18	19	31	47
Share Capital ⓘ	2	2	2	14
Reserves ⓘ	17	17	30	34
Debt +	30	27	27	28
Long Term Debt	17	14	16	15
Short Term Debt	13	12	12	13
Minority Interest	0	0	0	0
Trade Payables	4	12	11	9
Others Liabilities ⓘ	6	4	11	14
Total Liabilities ⓘ	58	61	81	98
Fixed Assets
Net Fixed Assets ⓘ +	15	13	22	21
Gross Block	49	51	64	68
Accumulated Depreciation	34	37	43	48
CWIP ⓘ	0	6	0	0
Investments ⓘ	0	0	0	0
Inventories	0	1	1	0
Trade Receivables	16	18	33	51
Cash Equivalents	9	2	15	5
Others Assets ⓘ	18	22	11	21
Total Assets ⓘ	58	61	81	98

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	14	6	18	-6
PBT ⓘ	9	1	16	21
Adjustment ⓘ	5	5	6	7
Changes in Working Capital ⓘ	2	1	-0	-29
Tax Paid ⓘ	-3	-0	-4	-5
Cash Flow From Investing Activity ⓘ +	-4	-9	-7	-4
Capex	-4	-9	-7	-4
Net Investments	0	0	0	0
Others ⓘ	0	0	0	0
Cash Flow From Financing Activity ⓘ +	-7	-5	2	-0
Net Proceeds from Shares ⓘ	0	0	0	0
Net Proceeds from Borrowing ⓘ	-5	-3	1	-1
Interest Paid ⓘ	-2	-2	-2	-2
Dividend Paid ⓘ	0	0	0	0
Others ⓘ	0	0	3	3
Net Cash Flow ⓘ	3	-7	13	-10

Finance Ratio

PARTICULARS	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	34.33	3.07	49.16	40.63
ROCE (%)	23.68	6.07	34.39	33.71
Asset Turnover Ratio	1.18	0.98	1.1	0.93
PAT to CFO Conversion(x)	2.33	6	1.5	-0.38
Working Capital Days
Receivable Days	86	105	117	183
Inventory Days	0	2	3	2
Payable Days	130	365	505	548

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Star Imaging and Path Lab Ltd FAQs

The current trading price of Star Imaging & Path on 17-Apr-2026 16:59 is ₹83.07.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Star Imaging & Path stood at ₹144.7 Cr

The latest P/E ratio of Star Imaging & Path as of 16-Apr-2026 is 9.09.

The latest P/B ratio of Star Imaging & Path as of 16-Apr-2026 is 1.25.

The 52-week high of Star Imaging & Path is ₹152.0 and the 52-week low is ₹46.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Star Imaging & Path is ₹83.24 ( Cr.) .

About Star Imaging and Path Lab Ltd

Star Imaging and Path Lab Limited was originally incorporated as a private limited company under the Companies Act, 1956 in the name and style of ‘Star Imaging & Path Lab Private Limited’ dated May 31, 2004, issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana. Subsequently, the company was converted into a Public Limited Company vide Special Resolution passed by the Shareholders at the Extra-Ordinary General Meeting, held on April 12, 2024, and consequently the name of the company was changed from ‘Star Imaging & Path Lab Private Limited’ to ‘Star Imaging and Path Lab Limited’ vide a fresh certificate of incorporation dated September 17, 2024 issued by Assistant Registrar of Companies/ Deputy Registrar of Companies/ Registrar of Companies of Central Processing Centre.

The company operates a diagnostic testing network, NABL accredited, delivering pathology, radiology, Cardiology, and Neurology services in Delhi (B2C, B2B & B2G model), Uttar Pradesh (B2G model), and Nasik (B2G Model) regions of India. It offers a comprehensive range of diagnostic imaging services and clinical laboratory tests, including both routine and specialized studies and profiles. These services are essential for the prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases.

Its diagnostic imaging and radiology services encompass X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry, and mammography. In the pathology segment, its services include biochemistry, hematology, clinical pathology, histopathology, cytopathology, microbiology, serology, and immunology. It also operates a tele-radiology hub, which is equipped with a full suite of diagnostic imaging equipment and supported by a skilled team of radiologists. This centralized facility provides significant operational efficiencies and scalability, ensuring quality diagnostic services are delivered consistently across the network.

Business area of the company

The company is primarily engaged in operating pathology and diagnostic centers. It offers a comprehensive range of diagnostic imaging services and clinical laboratory tests, including both routine and specialized studies and profiles. These services are essential for the prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases.

Services of the company

Radiology services
Pathology services
Diagnostic services

Awards and accreditation

2015: Best Imaging Service Provider of the Year from Six Sigma Healthcare Excellence Awards.
2015: IMA Natcon - 2015 Partners from Delhi Medical Association.
2016: Best Diagnostic & Imaging Centre from the Abs Achievement in Business & Services Awards.
2016: Certificate of Recognition for The Project Star Lifestyle Card from Health the Enterprise of Healthcare.
2016: Health Technology Brand of The Year from Indian Health & Wellness Awards 2016.
2017: Best Diagnostic Centre (Radiology & Laboratory Medicine) from The Health Care Achievers.
2017: Excellent Contribution in Branch Activities from IMA (Indian Medical Association) Janakpuri.
2019: Leading, Diagnostic & Imaging Centre from IMA Mediko Healthcare Excellence Awards.

History and milestones

2004: Incorporation of the company as a private company with the name ‘Star Imaging & Path Lab Private Limited’.
2011: Acquired Sole Proprietorship Firms (M/s Janta X-Ray Clinic, M/s Star Imaging & Path Lab, and M/s Star Health Care).
2017: The company formed a Subsidiary ‘Staredu Education and Training Institute Private Limited’ to expand its business activities.
2017: Received First Work Order under PPP (Public Private Partnership) model at Uttar Pradesh (Bijnor).
2022: The company received ISO 15189:2012 from NABL for Hub.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Star Imaging and Path Lab Ltd (544482) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Star Imaging & Path Share Price